Thankyou to Dr Georgia Soldatos, endocrinologist and research fellow at the Monash University School of Public Health and Population Medicine, who kindly gave us an update on current and emerging therapies in Diabetes and their particular relevance to treatment of Chinese patients.
Melanoma is, sadly, a problem that is “growing” on more and more Australians. ACMAV held a refresher seminar on this topic and also covered recent advances in melanoma management.
As a special treat, member Jason Chuen brought along some 3D-printed models!
Note: This seminar was supported by MSD Australia, distributors of pembrolizumab (Keytruda®), a new targeted anti-PD1 immunotherapy for metastatic melanoma which has been temporarily approved for use under the PBS under the Managed Entry Scheme (MES).